When did Moderna report Q1 2025 earnings?

Moderna (MRNA) reported Q1 2025 earnings on May 1, 2025 before market open.

What were Moderna's Q1 2025 revenue and EPS?

Moderna reported revenue of $107.0M and diluted EPS of $-2.52 for Q1 2025.

Did Moderna beat estimates in Q1 2025?

Revenue missed the consensus estimate of $116.7M by $9.7M. EPS beat the consensus estimate of $-2.92 by $0.40.

How did Moderna's Q1 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue declined 35.9% from $167.0M a year earlier and diluted EPS grew 17.9% from $-3.07.

Where can I find Moderna's Q1 2025 SEC filings?

You can read the 8-K earnings release (0001682852-25-000031) and the 10-Q periodic report (0001682852-25-000034) directly on SEC EDGAR. The filing index links above go to sec.gov.

Moderna MRNA Q1 2025 earnings

Reported May 1, 2025 · Before market open

Revenue$107.0MMiss by $9.7M Diluted EPS-$2.52Beat by $0.40

Revenue estimate$116.7M

EPS estimate-$2.92

Next report

Jul 31, 2026 (In 3 weeks)

Revenue estimate$101.7M

EPS estimate-$2.00

Financials

Q1 2025

Income statement

See full

Revenue$108.0M-35.3%

Gross profit$18.0M-74.6%

Operating income-$1.1B+17.1%

Net income-$971.0M+17.4%

EPS (diluted)-$2.52+17.9%

Balance sheet

See full

Cash & equivalents$1.6B-21.5%

Total debt$773.0M-37.5%

Total equity$10.1B-21.5%

Total assets$12.7B-24.1%

Cash flow

See full

Operating cash flow-$1.0B-4.9%

CapEx$117.0M-40.3%

Free cash flow-$1.2B+2.6%

Valuation & ratios

Valuation

as of 03/31/25

See full

Market cap$10.96B-73.1%

Enterprise value$10.11B-74.7%

P/S3.5×-4.5×

Profitability

See full

Gross margin54.1%+31.7pp

Operating margin-117.4%+25.0pp

Net margin-105.7%-11.3pp

FCF margin-136.2%—

Returns & leverage

See full

Return on equity-29.3%-5.8pp

Debt / equity0.1×0.0×

Current ratio4.2×+0.2×

Segments

By product

See full

Stand-ready manufacturing revenue$12.0M—

Licensing and royalty revenue$8.0M—

Collaboration Arrangement, Including Arrangements With Affiliate$1.0M—

Grant revenue$1.0M—

By geography

See full

Rest of world$173.0M—

Europe$13.3M-91.1%

Versus estimates

Revenue

Q1 2026$389.0MBeat by $152.6M Q4 2025$678.0MBeat by $42.8M Q3 2025$1.0BBeat by $95.1M Q2 2025$142.0MMiss by $751.3M

Q1 2025$107.0MMiss by $9.7M

Q4 2024$956.0MBeat by $13.2M

Diluted EPS

Q1 2026-$1.18Beat by $1.84 Q4 2025-$2.11Beat by $0.43 Q3 2025-$0.51Beat by $1.36 Q2 2025-$2.13Beat by $0.86

Q1 2025-$2.52Beat by $0.40

Q4 2024-$2.50Beat by $0.18

Ask the moment Moderna reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Moderna report Q1 2025 earnings?: Moderna (MRNA) reported Q1 2025 earnings on May 1, 2025 before market open.
What were Moderna's Q1 2025 revenue and EPS?: Moderna reported revenue of $107.0M and diluted EPS of $-2.52 for Q1 2025.
Did Moderna beat estimates in Q1 2025?: Revenue missed the consensus estimate of $116.7M by $9.7M. EPS beat the consensus estimate of $-2.92 by $0.40.
How did Moderna's Q1 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue declined 35.9% from $167.0M a year earlier and diluted EPS grew 17.9% from $-3.07.
Where can I find Moderna's Q1 2025 SEC filings?: You can read the 8-K earnings release (0001682852-25-000031) and the 10-Q periodic report (0001682852-25-000034) directly on SEC EDGAR. The filing index links above go to sec.gov.